GTPBP3
Basic information
Region (hg38): 19:17334920-17342731
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation defect type 23 (Strong), mode of inheritance: AR
- combined oxidative phosphorylation defect type 23 (Supportive), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 23 | AR | Cardiovascular | Among other multi-systemic manifestations, the condition may include cardiac manifestations such as hypertrophic cardiomyopathy, and surveillance may allow early diagnosis and management | Biochemical; Cardiovascular | 25434004 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (20 variants)
- Combined oxidative phosphorylation defect type 23 (3 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GTPBP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 121 | 129 | ||||
missense | 167 | 185 | ||||
nonsense | 9 | |||||
start loss | 1 | |||||
frameshift | 11 | 14 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 15 | 27 | 1 | 44 | |
non coding | 13 | 61 | 19 | 96 | ||
Total | 22 | 10 | 193 | 187 | 28 |
Highest pathogenic variant AF is 0.0000328
Variants in GTPBP3
This is a list of pathogenic ClinVar variants found in the GTPBP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-17335001-C-T | GTPBP3-related disorder | Likely benign (Jul 30, 2019) | ||
19-17335021-T-A | GTPBP3-related disorder | Likely benign (Oct 07, 2019) | ||
19-17335027-C-T | Likely benign (Oct 05, 2018) | |||
19-17335039-T-C | Likely benign (Aug 01, 2022) | |||
19-17335046-G-C | GTPBP3-related disorder | Likely benign (Jun 01, 2020) | ||
19-17335083-C-A | Inborn genetic diseases | Uncertain significance (Oct 06, 2021) | ||
19-17337486-G-A | Benign (Jul 09, 2018) | |||
19-17337596-C-G | not specified | Uncertain significance (Nov 04, 2022) | ||
19-17337613-T-A | Pathogenic (Nov 28, 2015) | |||
19-17337618-C-T | Uncertain significance (Jan 07, 2022) | |||
19-17337618-CG-C | Inborn genetic diseases | Pathogenic (Nov 24, 2021) | ||
19-17337619-G-A | Uncertain significance (May 12, 2022) | |||
19-17337619-G-C | not specified | Uncertain significance (Sep 01, 2016) | ||
19-17337619-G-T | Uncertain significance (Aug 23, 2022) | |||
19-17337621-G-A | Uncertain significance (Jul 01, 2022) | |||
19-17337622-G-T | Uncertain significance (Oct 30, 2023) | |||
19-17337628-G-A | See cases | Pathogenic/Likely pathogenic (Aug 18, 2023) | ||
19-17337640-C-T | Uncertain significance (Jul 15, 2022) | |||
19-17337643-AA-GTG | Combined oxidative phosphorylation defect type 23 | Pathogenic (Dec 04, 2014) | ||
19-17337645-G-T | Uncertain significance (Aug 10, 2022) | |||
19-17337646-C-A | Uncertain significance (Aug 20, 2021) | |||
19-17337656-G-A | GTPBP3-related disorder | Likely benign (Aug 27, 2023) | ||
19-17337669-G-C | Uncertain significance (Sep 01, 2022) | |||
19-17337670-G-A | Uncertain significance (Apr 09, 2021) | |||
19-17337674-C-G | Likely benign (Nov 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GTPBP3 | protein_coding | protein_coding | ENST00000358792 | 8 | 7816 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.19e-9 | 0.356 | 125710 | 0 | 37 | 125747 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0108 | 343 | 342 | 1.00 | 0.0000222 | 3267 |
Missense in Polyphen | 144 | 155.67 | 0.92505 | 1454 | ||
Synonymous | -0.425 | 171 | 164 | 1.04 | 0.0000114 | 1224 |
Loss of Function | 0.826 | 15 | 18.9 | 0.795 | 0.00000106 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000551 | 0.000425 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000135 | 0.000132 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000344 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase involved in the 5-carboxymethylaminomethyl modification (mnm(5)s(2)U34) of the wobble uridine base in mitochondrial tRNAs. {ECO:0000305}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]: An autosomal recessive mitochondrial disorder characterized by hypertrophic cardiomyopathy and/or neurologic symptoms with onset in early childhood. Disease features include hypertrophic cardiomyopathy, hypotonia, delayed psychomotor development, lactic acidosis, impaired activities of respiratory complexes I and IV, and defective translation of mitochondrial proteins. Disease severity is variable, ranging from death in early infancy to survival into the second decade of life. {ECO:0000269|PubMed:25434004, ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.167
Intolerance Scores
- loftool
- 0.548
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.44
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.428
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.900
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gtpbp3
- Phenotype
Zebrafish Information Network
- Gene name
- gtpbp3
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curved
Gene ontology
- Biological process
- tRNA wobble uridine modification;tRNA methylation;embryonic organ development
- Cellular component
- cytoplasm;mitochondrion
- Molecular function
- GTPase activity;protein binding;GTP binding